Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alejandro Villagra

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Molecular Cell|September 16, 2014
c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's diseaseMarcelo Gonzalez-Zuñiga, Pablo S Contreras, Lisbell D Estrada, et al.
Revista Medica De Chile|January 5, 2021
[Cancer immunotherapy: an update]Sebastián J Reyes, Konstanza B González, Constanza Rodríguez, et al.
The Oncologist|August 24, 2021
Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate CancerJianqing Lin, Jacob Elkon, Brittany Ricart, et al.
Nanomaterials (Basel, Switzerland)|January 23, 2020
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for MelanomaDebbie K Ledezma, Preethi B Balakrishnan, Juliana Cano-Mejia, et al.
Molecular Cancer Therapeutics|August 16, 2023
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 InhibitionSatish Kumar R Noonepalle, Scott Grindrod, Nima Aghdam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2022
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate CancersAmrita K Cheema, Yaoxiang Li, Mary Ventimiglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 28, 2024
Targeting HDAC6 improves anti-CD47 immunotherapyMaria Gracia-Hernandez, Ashutosh S Yende, Nithya Gajendran, et al.
Journal of Cellular Biochemistry|March 14, 2002
Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblastsAlejandro Villagra, José Gutiérrez, Roberto Paredes, et al.
Science Advances|November 15, 2024
The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapyDamian Kovalovsky, Satish Noonepalle, Manasa Suresh, et al.
Molecular and Cellular Biology|October 1, 2004
Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cellsRoberto Paredes, Gloria Arriagada, Fernando Cruzat, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Molecular Cell|September 16, 2014
c-Abl stabilizes HDAC2 levels by tyrosine phosphorylation repressing neuronal gene expression in Alzheimer's diseaseMarcelo Gonzalez-Zuñiga, Pablo S Contreras, Lisbell D Estrada, et al.
Revista Medica De Chile|January 5, 2021
[Cancer immunotherapy: an update]Sebastián J Reyes, Konstanza B González, Constanza Rodríguez, et al.
The Oncologist|August 24, 2021
Phase I Study of Entinostat in Combination with Enzalutamide for Treatment of Patients with Metastatic Castration-Resistant Prostate CancerJianqing Lin, Jacob Elkon, Brittany Ricart, et al.
Nanomaterials (Basel, Switzerland)|January 23, 2020
Indocyanine Green-Nexturastat A-PLGA Nanoparticles Combine Photothermal and Epigenetic Therapy for MelanomaDebbie K Ledezma, Preethi B Balakrishnan, Juliana Cano-Mejia, et al.
Molecular Cancer Therapeutics|August 16, 2023
Radiotherapy-induced Immune Response Enhanced by Selective HDAC6 InhibitionSatish Kumar R Noonepalle, Scott Grindrod, Nima Aghdam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 12, 2022
Radiotherapy Induces Innate Immune Responses in Patients Treated for Prostate CancersAmrita K Cheema, Yaoxiang Li, Mary Ventimiglia, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 28, 2024
Targeting HDAC6 improves anti-CD47 immunotherapyMaria Gracia-Hernandez, Ashutosh S Yende, Nithya Gajendran, et al.
Journal of Cellular Biochemistry|March 14, 2002
Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblastsAlejandro Villagra, José Gutiérrez, Roberto Paredes, et al.
Science Advances|November 15, 2024
The HDAC6 inhibitor AVS100 (SS208) induces a pro-inflammatory tumor microenvironment and potentiates immunotherapyDamian Kovalovsky, Satish Noonepalle, Manasa Suresh, et al.
Molecular and Cellular Biology|October 1, 2004
Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cellsRoberto Paredes, Gloria Arriagada, Fernando Cruzat, et al.
Pageof 6